Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

8.95
Delayed Data
As of Sep 29
 +0.05 / +0.56%
Today’s Change
6.00
Today|||52-Week Range
13.18
-14.44%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close8.90
Today’s open9.00
Day’s range8.72 - 9.00
Volume595,803
Average volume (3 months)368,353
Market cap$353.4M
Dividend yield--
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-33.68%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...-0.28-2.88%
CLSDClearside Biomedical...-1.04-5.93%
VSARVersartis Inc-0.08-0.65%
AKBAAkebia Therapeutics ...-0.36-3.96%
Data as of 09/29/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs